Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by NAOTO T UENO and BISRAT GODEFAY DEBEB.
NAOTO T UENO
Connection Strength
2.048
BISRAT GODEFAY DEBEB
  1. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst. 2022 04 11; 114(4):579-591.
    View in: PubMed
    Score: 0.207
  2. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021 01 15; 4(1):72.
    View in: PubMed
    Score: 0.190
  3. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers (Basel). 2020 Dec 10; 12(12).
    View in: PubMed
    Score: 0.189
  4. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. J Cancer. 2017; 8(17):3607-3614.
    View in: PubMed
    Score: 0.152
  5. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget. 2016 May 10; 7(19):28329-39.
    View in: PubMed
    Score: 0.137
  6. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8).
    View in: PubMed
    Score: 0.137
  7. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res. 2014 Jul 23; 33:58.
    View in: PubMed
    Score: 0.121
  8. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/?-catenin signaling. Stem Cells. 2012 Nov; 30(11):2366-77.
    View in: PubMed
    Score: 0.108
  9. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer. 2010 Jul 08; 9:180.
    View in: PubMed
    Score: 0.092
  10. Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):889-95.
    View in: PubMed
    Score: 0.089
  11. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol. 2021 10; 15(10):2752-2765.
    View in: PubMed
    Score: 0.050
  12. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med. 2021 09; 10(18):6261-6272.
    View in: PubMed
    Score: 0.049
  13. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Sci Rep. 2020 05 22; 10(1):8537.
    View in: PubMed
    Score: 0.045
  14. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Mol Oncol. 2020 03; 14(3):504-519.
    View in: PubMed
    Score: 0.045
  15. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Hum Pathol. 2018 07; 77:121-129.
    View in: PubMed
    Score: 0.039
  16. Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer. 2018 06 01; 124(11):2299-2305.
    View in: PubMed
    Score: 0.039
  17. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. J Cancer. 2017; 8(10):1726-1732.
    View in: PubMed
    Score: 0.037
  18. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget. 2016 Dec 13; 7(50):82482-82492.
    View in: PubMed
    Score: 0.036
  19. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016 Apr; 29(4):330-46.
    View in: PubMed
    Score: 0.034
  20. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in?Breast Cancer. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):791-9.
    View in: PubMed
    Score: 0.034
  21. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Res Treat. 2015 Dec; 154(3):495-508.
    View in: PubMed
    Score: 0.033
  22. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. PLoS One. 2015; 10(7):e0132710.
    View in: PubMed
    Score: 0.033
  23. High-density and very-low-density lipoprotein?have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1072-80.
    View in: PubMed
    Score: 0.032
  24. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Res. 2015 Mar 20; 17:42.
    View in: PubMed
    Score: 0.032
  25. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med. 2014 Jul; 3(7):849-56.
    View in: PubMed
    Score: 0.030
  26. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS One. 2014; 9(1):e83113.
    View in: PubMed
    Score: 0.029
  27. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One. 2013; 8(8):e71508.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.